Colorectal Cancer Survival Probability Calculator
Understand the NCI colorectal cancer survival probability calculator and how it differs from recurrence and surgical-risk tools.
Quick Navigation
1. Official NCI Tool
The NCI Division of Cancer Epidemiology and Genetics provides a colorectal cancer survival probability calculator for health professionals. It estimates five-year cancer-specific survival probability, meaning the probability that a patient with colorectal cancer will not die from colorectal cancer in the next five years.1
Official tool: NCI DCEG colorectal cancer survival probability calculator.
The tool was developed by Eric A. Engels, M.D., M.P.H., and colleagues at NCI DCEG. NCI describes it as a health-professional tool that may be useful for clinical decision-making, including contexts such as solid organ transplant evaluation in patients with a history of colorectal cancer.1, 2
Clinical caution
This guide links to the official NCI calculator rather than recreating a restricted or complex survival model. Use the NCI output as a population-derived starting point and interpret it with current disease status, molecular data, treatment response, and clinician judgment.
2. What It Estimates
Cancer-specific survival is not the same as overall survival or relative survival.
| Measure | Plain-Language Meaning | Key Limitation |
|---|---|---|
| Cancer-specific survival | Probability of not dying from colorectal cancer over a defined period | Does not count deaths from other causes as events. |
| Overall survival | Probability of being alive regardless of cause of death | Affected by comorbidities, age, treatment toxicity, and non-cancer mortality. |
| Relative survival | Survival compared with expected survival in the general population | Often reported by SEER stage groups, not detailed TNM or molecular subgroups.4 |
NCI states that the calculator is based on statistical modeling of 230,465 patients with colorectal cancer diagnosed from 2004 to 2015 in SEER registries. It uses a cure-model approach and translates cure probabilities into five-year cancer-specific survival estimates for clinical interpretation.1, 3
3. Inputs and Interpretation
The NCI page describes the model as using readily available demographic and clinical information:
| Input Domain | Examples | Clinical Check |
|---|---|---|
| Patient factors | Sex and age at diagnosis | Confirm whether the estimate is being made at diagnosis or later in survivorship. |
| Cancer subsite | Proximal colon, distal colon, or rectum | Subsite can be prognostically meaningful and may correlate with molecular patterns. |
| Stage | Stage at diagnosis | Confirm pathologic versus clinical stage and any post-neoadjuvant context. |
| Initial treatment | Surgery, radiation, and chemotherapy | Remember the model does not encode detailed regimen, dose intensity, or response. |
NCI explicitly cautions that the estimates are average population-level probabilities. They do not account for molecular tumor characteristics, detailed treatment information, updated imaging, recurrence status, or all patient-specific clinical factors.1
4. Related OncoToolkit Calculators
OncoToolkit currently provides practical colorectal tools for recurrence and disease-specific workflows. These tools answer different questions than five-year cancer-specific survival:
| Clinical Question | Tool | Use When |
|---|---|---|
| Five-year cancer-specific survival | NCI DCEG survival calculator | You need a population-derived colorectal cancer-specific survival estimate. |
| Stage II adjuvant risk features | Stage II Colon Cancer Recurrence Risk | You are discussing high-risk features and adjuvant therapy after resection. |
| Recurrence after liver metastasis resection | Fong Clinical Risk Score | You are counseling after planned or completed colorectal liver metastasis resection. |
| Peritoneal tumor burden | Peritoneal Carcinomatosis Index | You need to quantify peritoneal disease extent across 13 regions. |
| CRS-HIPEC decision context | PCI CRS-HIPEC Workflow | You want PCI scoring plus cautious small-bowel burden and CRS-HIPEC interpretation. |
For broader disease context, visit the colorectal cancer hub, colorectal guideline hub, early-stage colon guideline, early-stage rectum guideline, and metastatic CRC guideline.
5. Practical Workflow
- Clarify the endpoint. Decide whether the question is cancer-specific survival, overall survival, relative survival, recurrence risk, surgical feasibility, or adjuvant treatment benefit.
- Use the official NCI tool for five-year cancer-specific survival. Enter demographics, subsite, stage, and initial treatment information as requested by the NCI calculator.
- Check what the model cannot see. Review MSI/MMR, RAS, BRAF, HER2, NTRK, ctDNA when available, treatment response, recurrence status, performance status, organ function, and current imaging.
- Choose additional tools only when the question changes. Use stage II recurrence tools for adjuvant risk features, Fong CRS for liver metastasis resection recurrence, and PCI for peritoneal disease burden.
- Communicate uncertainty clearly. Explain that a model estimate is a population-derived starting point, not a deterministic prediction for one person.
6. FAQ
What does the NCI colorectal survival calculator estimate?
It estimates the probability that a patient with colorectal cancer will not die from colorectal cancer in the next five years. This is a cancer-specific survival concept, not an all-cause survival estimate.
Can I use SEER stage survival tables instead?
SEER stage survival tables are useful for broad counseling, but they group disease into localized, regional, and distant categories. The NCI calculator uses more detailed model inputs and is a better fit when an individualized cancer-specific survival estimate is needed.
Does cancer-specific survival include competing risks?
It focuses on death from colorectal cancer. Other health conditions remain clinically important, especially in older adults, but they are not the same endpoint as colorectal cancer-specific death.
Choose the Right Colorectal Prognosis Tool
Use the official NCI survival calculator for cancer-specific survival, and OncoToolkit calculators for recurrence and workflow-specific decisions.
Open the Colorectal Cancer HubReferences
- NCI DCEG. Calculator of Colorectal Cancer Survival Probability. Source
- NCI DCEG News. Tool Estimates Colorectal Cancer Survival for Patients in Need of Organ Transplantation. Source
- Engels EA, et al. Cure models, survival probabilities, and solid organ transplantation for patients with colorectal cancer. Am J Transplant. 2024. PubMed
- American Cancer Society. Survival Rates for Colorectal Cancer. Source
- UT MD Anderson Cancer Center. Colon Cancer Survival Calculator. Source